tiprankstipranks
Vanda (NASDAQ:VNDA) Soars After U.S. FDA Greenlights Fanapt for Bipolar Disorder
PremiumMarket NewsVanda (NASDAQ:VNDA) Soars After U.S. FDA Greenlights Fanapt for Bipolar Disorder
17d ago
Vanda Pharmaceuticals’ Fanapt receives FDA approval
PremiumThe Fly
Vanda Pharmaceuticals’ Fanapt receives FDA approval
17d ago
Vanda Pharmaceuticals receives CRL from FDA regarding sNDA for HETLIOZ
PremiumThe Fly
Vanda Pharmaceuticals receives CRL from FDA regarding sNDA for HETLIOZ
1M ago
VNDA Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsVNDA Upcoming Earnings Report: What to Expect?
2M ago
Vanda Pharmaceuticals: FDA approves IND application to evaluate VTR-297
PremiumThe Fly
Vanda Pharmaceuticals: FDA approves IND application to evaluate VTR-297
3M ago
Court orders FDA to resolve Vanda’s jet lag hearing request by March 4
PremiumThe Fly
Court orders FDA to resolve Vanda’s jet lag hearing request by March 4
3M ago
Vanda Pharmaceuticals says court denied in part U.S. motion to dismiss
PremiumThe FlyVanda Pharmaceuticals says court denied in part U.S. motion to dismiss
3M ago
Vanda announces publication of journal article on Fanapt study
PremiumThe Fly
Vanda announces publication of journal article on Fanapt study
3M ago
Vanda comments on FDA’s recently announced guidance on communication
PremiumThe Fly
Vanda comments on FDA’s recently announced guidance on communication
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100